Investors need to face the fact that the sector's best growth days may be behind it. North Chicago's AbbVie is a case in point.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180716/NEWS03/180719899/big-pharmas-metabolism-is-slowing-down?utm_source=NEWS03&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment